# Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

> **NCT02950922** · PHASE2 · COMPLETED · sponsor: **Dermavant Sciences GmbH** · enrollment: 157 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** RVT-501 0.2% ointment
- **DRUG:** RVT-501 0.5% ointment
- **OTHER:** Vehicle ointment

## Key facts

- **NCT ID:** NCT02950922
- **Lead sponsor:** Dermavant Sciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-07-03
- **Final completion:** 2017-07-03
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2018-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950922, "Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02950922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*